{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:47:27Z","timestamp":1772758047646,"version":"3.50.1"},"publisher-location":"Chichester, UK","update-to":[{"DOI":"10.1002\/14651858.cd003643","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000},"record-id":"34028"},{"DOI":"10.1002\/14651858.cd003643.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000},"record-id":"34027"}],"reference-count":20,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003643.pub3","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T13:46:57Z","timestamp":1256132817000},"source":"Crossref","is-referenced-by-count":8,"title":["Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis"],"prefix":"10.1002","author":[{"given":"Ernest HS","family":"Choy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Lecky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B","family":"Winer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003643.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","article-title":"Azathioprine with prednisone for polymyositis","volume":"92","author":"Bunch","year":"1980","journal-title":"Annals of Internal Medicine"},{"issue":"27","key":"10.1002\/14651858.CD003643.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD003643.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","article-title":"Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis","volume":"326","author":"Miller","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003643.pub3-BIB4|cit4","first-page":"S53","article-title":"Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy","volume":"199","author":"Miller","year":"2002","journal-title":"Journal of the Neurological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD003643.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","article-title":"Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis","volume":"29","author":"Vencovsky","year":"2000","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD003643.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine for polymyositis: long-term follow up","volume":"24","author":"Bunch","year":"1981","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000110327","article-title":"Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county","volume":"12","author":"Ahlstrom","year":"1993","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD003643.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003643.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003643.pub3-BIB11|cit11","first-page":"207","article-title":"Survival in polymyositis: corticosteroids and risk factors","volume":"4","author":"Carpenter","year":"1977","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/41.1.7","article-title":"Treatment of dermatomyositis and polymyositis","volume":"41","author":"Choy","year":"2002","journal-title":"Rheumatology"},{"issue":"21","key":"10.1002\/14651858.CD003643.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis, and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00002826-199210000-00001","article-title":"Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies","volume":"15","author":"Dalakas","year":"1992","journal-title":"Clinical Neuropharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jnnp.70.5.569","article-title":"Progress in inflammatory myopathies: good but not good enough","volume":"70","author":"Dalakas","year":"2001","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003643.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-510X(75)90115-X","article-title":"Prognosis in adult polymyositis","volume":"26","author":"Riddoch","year":"1975","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/art.20078","article-title":"Quality of myositis case reports open to improvement","volume":"51","author":"Vlekkert","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003643.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003643.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:23:45Z","timestamp":1628529825000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003643.pub3"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003643.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003643.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}